The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Maarten Jan Suttorp
Showing 1-17 of 17 articles
Optical coherence tomography findings: insights from the “randomised multicentre trial investigating angiographic outcomes of hybrid sirolimus-eluting stents with biodegradable polymer compared with everolimus-eluting stents with durable polymer in chronic total occlusions” (PRISON IV) trial
Teeuwen K,
Spoormans E,
Bennett J,
Dubois C,
Desmet W,
Ughi G,
Belmans A,
Kelder J,
Tijssen J,
Agostoni P,
Suttorp MJ,
Adriaenssens T
August 4, 2017 | 10.4244/EIJ-D-17-00261
Evaluation of a crystalline sirolimus-eluting coronary stent with a bioabsorbable polymer designed for rapid dissolution: two-year outcomes from the DESSOLVE I and II trials
Wijns W,
Suttorp MJ,
Zagozdzon L,
Morice M,
McClean D,
Stella P,
Donohoe D,
Knape C,
Ormiston J
June 20, 2016 | 10.4244/EIJY15M09_14
Initial experience with therapeutic geometric modification of the carotid bulb for true resistant hypertension
Habib N,
Mahmoodi BK,
Bos WJ,
Tromp SC,
Suttorp MJ,
Bates MC,
Van der Heyden J
May 19, 2015 | 10.4244/EIJV11I1A20
Three-year clinical outcome in the Primary Stenting of Totally Occluded Native Coronary Arteries III (PRISON III) trial: a randomised comparison between sirolimus-eluting stent implantation and zotarolimus-eluting stent implantation for the treatment of total coronary occlusions
Teeuwen K,
Van den Branden B,
Koolen J,
van der Schaaf RJ,
Henriques J,
Thijssen J,
Kelder J,
Vermeersch P,
Rensing B,
Suttorp MJ
March 20, 2015 | 10.4244/EIJY14M08_07
Percutaneous reclosure of a patent foramen ovale after bioabsorbable device implantation
Snijder R,
Post M,
Suttorp MJ
November 20, 2014 | 10.4244/EIJV10I7A146
Primary Stenting of Totally Occluded Native Coronary Arteries III (PRISON III): a randomised comparison of sirolimus-eluting stent implantation with zotarolimus-eluting stent implantation for the treatment of total coronary occlusions
Van den Branden B,
Teeuwen K,
Koolen J,
van der Schaaf RJ,
Henriques J,
Thijssen J,
Kelder J,
Vermeersch P,
Rensing B,
Suttorp MJ
November 29, 2013 | 10.4244/EIJV9I7A138
Late catch-up in lumen diameter at five-year angiography in MACE-free patients treated with sirolimus-eluting stents in the Primary Stenting of Totally Occluded Native Coronary Arteries: a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (PRISON II)
Teeuwen K,
Van den Branden B,
Rahel B,
Laarman G,
Thijssen J,
Kelder J,
Slagboom T,
ten Berg J,
Suttorp MJ
June 28, 2013 | 10.4244/EIJV9I2A36
Five-year clinical outcome after primary stenting of totally occluded native coronary arteries: a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (PRISON II study)
Van den Branden B,
Rahel B,
Laarman G,
Slagboom T,
Kelder J,
ten Berg J,
Suttorp MJ
February 21, 2012 | 10.4244/EIJV7I10A190
Comparison of outcome after patent foramen ovale closure in older versus younger patients
Luermans J,
Budts W,
ten Berg J,
Plokker H,
Suttorp MJ,
Post M
June 30, 2011 | 10.4244/EIJV7I2A35
CT measurement of changes in cerebral perfusion in patients with asymptomatic carotid artery stenosis undergoing carotid stenting prior to cardiac surgery: "proof of principle"
Van der Heyden J,
Waaijer A,
Van ES W,
van Neerven D,
Sonker U,
Suttorp MJ,
Bal E,
Prokop M
April 20, 2011
Long-term follow-up of the randomised controlled trial to evaluate the safety and efficacy of the zotarolimus-eluting driver coronary stent in de novo native coronary artery lesions: five year outcomes in the ENDEAVOR II study
Fajadet J,
Wijns W,
Laarman GJ,
Kuck K,
Ormiston J,
Baldus S,
Hauptmann K-E,
Suttorp MJ,
Drzewiecki J,
Pieper M,
Schultheiss H-P,
Mauri L
November 15, 2010
Long-term outcome of percutaneous closure of secundum-type atrial septal defects in adults
Luermans J,
Post M,
ten Berg J,
Plokker H,
Suttorp MJ
November 15, 2010
The BioSTAR® device versus the CardioSEAL® device in patent foramen ovale closure: comparison of mid-term efficacy and safety
Van den Branden B,
Luermans J,
Post M,
Plokker H,
ten Berg J,
Suttorp MJ
September 30, 2010
Two year follow-up after primary PCI with a paclitaxel-eluting stent versus a bare-metal stent for acute ST-elevation myocardial infarction (the PASSION trial): a follow-up study
Dirksen M,
Vink M,
Suttorp MJ,
Thijssen J,
Patterson M,
Slagboom T,
Kiemeneij F,
Laarman GJ
May 13, 2008
A novel ultra-thin bare metal stent (BMS): results from a worldwide registry
Blanchard D,
Danzi G,
Urban P,
Moseri M,
Juergens C,
Guyton R,
Nowak B,
Tresukosol D,
Suttorp MJ,
Farshid A,
Kornowski R,
Garcia E,
Yeend R,
Nagai H,
Paunovic D
August 20, 2007
Safety of direct stenting with the Endeavor stent: results of the Endeavor II continued access registry
Schultheiss H-P,
Grube E,
Kuck K,
Suttorp MJ,
Heuer H,
Bonnier H,
Popma J,
Kuntz R,
Fajadet J,
Wijns W
May 22, 2007
One-year results of coronary revascularization in diabetic patients with multivessel coronary artery disease.
Macaya C,
Garcia-Garcia H,
Colombo A,
Morice M,
Legrand V,
Kuck K,
Sheiban I,
Suttorp MJ,
Carrié D,
Vrolix M,
Wittebols K,
Stoll H,
Donohoe D,
Bressers M,
Serruys P
May 20, 2006
1
Latest news
AHEAD OF PRINT
Two-year outcomes after TMVR
FREE ARTICLE - Sebastian Ludwig et al
May 26, 2023
Simultaneous Publications at EuroPCR 2023!
May 12, 2023
NEW ISSUE
Debating Invasive Coronary Testing in INOCA Patients; Single Antiplatelet Therapy After PCI; Ultrasound-Guided Femoral Access in the UNIVERSAL Trial
May 12, 2023
AHEAD OF PRINT
BIOSOLVE-IV registry
FREE ARTICLE - Adrian Wlodarczak et al
May 24, 2023
AHEAD OF PRINT EUROPCR
The EURO SHOCK Trial
FREE ARTICLE - Amerjeet Singh Banning et al
May 19, 2023
AHEAD OF PRINT EUROPCR
Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve (DurAVR)
FREE ARTICLE - Susheel K. Kodali et al
May 19, 2023
AHEAD OF PRINT EUROPCR
TAVI for bicuspid aortic valves with Evolut platform
FREE ARTICLE - Didier Tchétché et al
May 18, 2023
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke